All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Market weighs XO as hedge for CLOs

The touting of Crossover tranches as a hedge for CLO investments has prompted debate in the market, with some seeing the instrument as adding a useful tool while others remain sceptical.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree